The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial

Table 3 Maternal outcomes between the vitamin and placebo groups

Characteristic	Vitamin C	Placebo	Risk ratio	P value
Characteristic	N = 415	N = 418	Risk ratio	P value
Pre-eclampsia
Yes	13 (3.1)	17 (4.1)	0.77 (0.37-1.56)	0.4
Severe pre-eclampsia
Yes	5 (1.2)	4 (1.0)	1.25 (0.34-4.65)	0.72
Gestational hypertension
Yes	32 (7.7)	48 (11.5)	0.67 (0.43-1.03)	0.06
Ante partum haemorrhage
Yes	7 (1.7)	9 (2.2)	0.78 (0.29-2.1)	0.6
Premature rupture of membranes
Yes	15 (3.6)	19 (4.6)	0.79 (0.41-1.54)	0.5
Abruption
Yes	1 (0.2)	2 (0.5)	0.5 (0.04-5.53)	0.6
Delivery route
Vaginal	278 (67.0)	281 (67.2)	1.0 (0.82-1.22)	0.9
Caesarean	137 (33.0)	137 (32.8)
Twin delivery
Yes	14 (3.4)	11 (2.6)	1.28 (0.59-2.79)	0.5
Eclampsia
Yes	0 (0)	2 (0.5)	0

ISSN: 1471-2393